These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
948 related items for PubMed ID: 16496609
1. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia]. Nowakowska A. Ann Acad Med Stetin; 2005; 51(1):95-105. PubMed ID: 16496609 [Abstract] [Full Text] [Related]
2. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia]. Jastrzebska M, Widecka K, Ciechanowicz A, Goracy I, Wesołowska T, Torbus-Lisiecka B, Foltyńska-Nowakowska A, Naruszewicz M. Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596 [Abstract] [Full Text] [Related]
3. ACE/DD genotype is associated with hemostasis balance disturbances reflecting hypercoagulability and endothelial dysfunction in patients with untreated hypertension. Makris TK, Stavroulakis GA, Dafni UG, Gialeraki AE, Krespi PG, Hatzizacharias AN, Tsoukala CG, Vythoulkas JS, Kyriakidis MK. Am Heart J; 2000 Nov; 140(5):760-5. PubMed ID: 11054622 [Abstract] [Full Text] [Related]
4. [The hemostasis parameters and ACE gene polymorphism in patients with essential hypertension treated with perindopril]. Janczak-Bazan A. Ann Acad Med Stetin; 2006 Nov; 52(1):51-61; discussion 61-2. PubMed ID: 17131847 [Abstract] [Full Text] [Related]
5. Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis. Emingil G, Berdeli A, Gürkan A, Han Saygan B, Köse T, Atilla G. J Clin Periodontol; 2007 Apr; 34(4):278-84. PubMed ID: 17257155 [Abstract] [Full Text] [Related]
6. Influence of the 4G/5G PAI-1 genotype on angiotensin II-stimulated human endothelial cells and in patients with hypertension. Roncal C, Orbe J, Rodriguez JA, Belzunce M, Beloqui O, Diez J, Páramo JA. Cardiovasc Res; 2004 Jul 01; 63(1):176-85. PubMed ID: 15194475 [Abstract] [Full Text] [Related]
7. Effects of perindopril treatment on hemostatic function in patients with essential hypertension in relation to angiotensin converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms. Jastrzebskal M, Widecka K, Naruszewicz M, Ciechanowicz A, Janczak-Bazan A, Foltynska A, Goracy I, Chetstowski K, Wesotowska T. Nutr Metab Cardiovasc Dis; 2004 Oct 01; 14(5):259-69. PubMed ID: 15673060 [Abstract] [Full Text] [Related]
8. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis. Sartori MT, Wiman B, Vettore S, Dazzi F, Girolami A, Patrassi GM. Thromb Haemost; 1998 Dec 01; 80(6):956-60. PubMed ID: 9869167 [Abstract] [Full Text] [Related]
9. [The influences of genetic and environmental factors on plasma plasminogen activator inhibitor-1 levels in patients with essential hypertension]. Song Y, Xu W, Chen Y, Che L, Wang Q, Zhou X, Wu J. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Dec 01; 16(6):374-6. PubMed ID: 10581347 [Abstract] [Full Text] [Related]
10. Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity. Castelló R, España F, Vázquez C, Fuster C, Almenar SM, Aznar J, Estellés A. Thromb Res; 2006 Dec 01; 117(5):487-92. PubMed ID: 15907980 [Abstract] [Full Text] [Related]
11. [The role of 4G/5G polymorphism in the regulation of plasma levels of PAI-1: a model of interaction between genetic and environmental factors]. Burzotta F, Di Castelnuovo A, Amore C, D'Orazio A, Donati MB, Iacoviello L. Cardiologia; 1998 Jan 01; 43(1):83-8. PubMed ID: 9534297 [Abstract] [Full Text] [Related]
12. Insertion/deletion polymorphism on ACE gene is associated with endothelial dysfunction in young patients with hypertension. Penesova A, Cizmarova E, Kvetnansky R, Koska J, Sedlakova B, Krizanova O. Horm Metab Res; 2006 Sep 01; 38(9):592-7. PubMed ID: 16981142 [Abstract] [Full Text] [Related]
13. Plasminogen activator inhibitor 1 (PAI-1) levels and gene promoter polymorphisms in subjects with colorectal cancer. Smolarz B, Blasiak J, Kulig A, Romanowicz-Makowska H, Dziki A, Ulanska J, Pander B, Szewczyk T. J Exp Clin Cancer Res; 2001 Jun 01; 20(2):247-52. PubMed ID: 11484982 [Abstract] [Full Text] [Related]
14. Angiotensin converting enzyme insertion/deletion polymorphism is associated with plasma antigen levels of plasminogen activator inhibitor-1 in healthy Japanese population. Matsubara Y, Hayakawa T, Tsuda T, Takeshita E, Watanabe G, Murata M, Watanabe K, Ikeda Y. Blood Coagul Fibrinolysis; 2000 Mar 01; 11(2):115-20. PubMed ID: 10759003 [Abstract] [Full Text] [Related]
15. Tissue plasminogen activator and plasminogen activator inhibitor-1 gene polymorphisms in patients with chronic periodontitis. Gürkan A, Emingil G, Saygan BH, Cinarcik S, Atilla G, Köse T, Berdeli A. J Periodontol; 2007 Jul 01; 78(7):1256-63. PubMed ID: 17608581 [Abstract] [Full Text] [Related]
16. [Relationship between the 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and the pathogenesis of pregnancy-induced hypertension syndrome]. Guan LX, Du XY, Wang JX, Wang RL, Wu ZL, Jiang H. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr 01; 21(2):173-5. PubMed ID: 15079805 [Abstract] [Full Text] [Related]
17. The effect of plasminogen activator inhibitor-1 gene 4G/5G polymorphism on glucose and lipid metabolisms in Turkish obese children. Kinik ST, Ataç FB, Verdi H, Cetintaş S, Sahin FI, Ozbek N. Clin Endocrinol (Oxf); 2005 May 01; 62(5):607-10. PubMed ID: 15853833 [Abstract] [Full Text] [Related]
18. Are polymorphisms in the ACE and PAI-1 genes associated with recurrent spontaneous miscarriages? Goodman C, Hur J, Goodman CS, Jeyendran RS, Coulam C. Am J Reprod Immunol; 2009 Dec 01; 62(6):365-70. PubMed ID: 19821806 [Abstract] [Full Text] [Related]
19. Relationships between fibrinogen, plasminogen activator inhibitor-1, and their gene polymorphisms in current smokers with essential hypertension. Jastrzebska M, Goracy I, Naruszewicz M. Thromb Res; 2003 Jun 15; 110(5-6):339-44. PubMed ID: 14592559 [Abstract] [Full Text] [Related]
20. The gender-specific role of polymorphisms from the fibrinolytic, renin-angiotensin, and bradykinin systems in determining plasma t-PA and PAI-1 levels. Asselbergs FW, Williams SM, Hebert PR, Coffey CS, Hillege HL, Navis G, Vaughan DE, van Gilst WH, Moore JH. Thromb Haemost; 2006 Oct 15; 96(4):471-7. PubMed ID: 17003924 [Abstract] [Full Text] [Related] Page: [Next] [New Search]